Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000313

Drug Information
SynonymsDozic; H1512_SIGMA; H0912; Lealgin compositum; KBio2_001341; MolPort-000-883-311; Galoperidol; Tocris-0931; KBio3_001316; McN-JR-1625; Einalon S; HMS2091J09; NCGC00023875-04; KBioGR_000980; KBio2_006477; NCGC00023875-07; Peluces; NSC 615296; Aloperidolo [Italian]; NSC170973; BRN 0331267; EINECS 200-155-6; SPECTRUM1500325; CAS-52-86-8; Aloperidol; Linton; Sigaperidol; KBioSS_002395; Prestwick_250; BPBio1_000144; UNII-J6292F8L3D; NINDS_000654; Halopidol; CHEBI:5613; Haloperidol [USAN:INN:BAN:JAN]; HMS1568G12; Haloperidolum [INN-Latin]; Haloperidolum; 52-86-8; AKOS000280660; Spectrum3_000448; Spectrum4_000570; R-1625; DivK1c_000654; NCGC00023875-08; Bioperidolo; Novo-Peridol; BPBio1_001231; NSC615296; Oprea1_509923; BRD-K67783091-001-05-5; Uliolind; Serenase; IDI1_000654; I14-13404; KBioGR_002390; Prestwick1_000115; LS-48311; Sernel; Aloperidin; Peridol; Halosten; HMS2089M15; Biomol-NT_000035; KBio2_002390; NCGC00015500-02; Prestwick3_000115; D00136; Probes1_000255; Haldol; Lopac0_000583; NCGC00015500-06; Aloperidolo; AC1L1G7K; Halopoidol; 5-21-02-00377 (Beilstein Handbook Reference); BIDD:GT0128; AB00052008; AC1Q77Z0; HMS502A16; NSC 170973; Halidol; BRD-K67783091-001-04-8; Spectrum_000861; EU-0100583; SMR000058303; Lopac-H-1512; I14-14165; NCGC00015500-01; Haldol Solutab; Serenelfi; Pernox; DB00502; KBio3_002869; MLS000028450; CCRIS 1630; NCGC00023875-09; WLN: T6NTJ A3VR DF& DQ DR DG; Vesalium; Dozix; cMAP_000037; Apo-Haloperidol; AC-19691; MLS001146904; KBio2_007526; Spectrum5_000788; Ulcolind; Prestwick2_000115; Bio-0705; Keselan; CID3559; NCGC00023875-06; D006220; Sernas; LNEPOXFFQSENCJ-UHFFFAOYSA-; NCGC00015500-14; C21H23ClFNO2; Aloperidon; C01814; Halol; NCGC00023875-05; Haldol La; HMS1920D03; Probes2_000296; S1920_Selleck; HSDB 3093; Halopal; Serenace; Eukystol; H 1512; CHEMBL54; Brotopon; QTL1_000042; Spectrum2_001268; Pekuces; Haloperido; NCGC00023875-02; SPBio_002069; BSPBio_002096; BSPBio_000130; KBio1_000654; haloperidol; KBio2_004958; Pms Haloperidol; Prestwick0_000115; R 1625; Aldo; Fortunan; SPBio_001236; KBio2_003909; KBioSS_001341; Halojust; Haloperidol (JP15/USP); L000288; Aloperidolo [DCIT]; Haloperidol (JP15/USP/INN); Mixidol; NCGC00016234-01
Trade NameAloperidin; Bioperidolo; Brotopon; Dozic; Duraperidol; Einalon S; Eukystol; Haldol; Halosten; Keselan; Linton; Peluces; Serenace; Serenase; Sigaperidol
CompanyJanssen Pharmaceutica
[ICD9: 295   ICD10: F20]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F    
Therapeutic ClassAntipsychotic Agents
CAS NumberCAS 52-86-8
PubChem Compound IDCID 3559.
PubChem Substance IDSID 4938.
SuperDrug ATC IDN05AD01
SuperDrug CAS ID000052868;
TargetD(2) dopamine receptorAntagonist[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment. Synapse. 2002 Aug;45(2):78-85. To Reference
Ref 3Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543